Detail page

Knowledge Web

Person

Albrecht Stenzinger

Arzt

Name	Albrecht Stenzinger
Place	Heidelberg (Wirkungsort) Deutschland
Academic degree	Dr. med. (Universität Gießen) (2009)
Profession	Arzt (characteristic profession)
Variant	A. Stenzinger
Related	Universität Heidelberg. Pathologisches Institut
Further information	Leiter Molekularpathologisches Zentrum
Record type	Person
GND-Identifier	139606106
Record ID	139606106
Involved in show all Molecular diagnostics of hepatobiliary and pancreatic neoplasias Stratifying esophago-gastric cancer treatment using a patient-derived organoid-based threshold AWMF statement on medical services in laboratory diagnostics and pathology with regard to the IVDR Benchmarking whole exome sequencing in the German network for personalized medicine First-line immunotherapy for lung cancer with MET exon 14 skipping and the relevance of TP53 mutations First-line immunotherapy for lung cancer with MET exon 14 skipping and the relevance of TP53 mutations Der Biomarker POLE in der Tumorpathologie Acute expression of human APOBEC3B in mice results in RNA editing and lethality Addressing image misalignments in multi-parametric prostate MRI for enhanced computer-aided diagnosis of prostate cancer NCT/DKFZ MASTER handbook of interpreting whole-genome, transcriptome, and methylome data for precision oncology Nivolumab and ipilimumab in recurrent or refractory cancer of unknown primary: a phase II trial Multicentric pilot study to standardize clinical whole exome sequencing (WES) for cancer patients Current challenges and practical aspects of molecular pathology for non-small cell lung cancers High EVI1 and PARP1 expression as favourable prognostic markers in high-grade serous ovarian carcinoma Erratum: Molekulare Tumordiagnostik als Triebfeder der Präzisionsonkologie An uncommon cause of recurrent presyncope, dizziness, and tachycardia: a case report of diffuse, adult-onset nesidioblastosis/non-insulinoma pancreatogenous hypoglycemia syndrome (NIPHS) Diffuse, adult-onset nesidioblastosis/non-insulinoma pancreatogenous hypoglycemia syndrome (NIPHS): review of the literature of a rare cause of hyperinsulinemic hypoglycemia Multicentric pilot study to standardize clinical whole exome sequencing (WES) for cancer patients Longitudinal monitoring of cell-free DNA methylation in ALK-positive non-small cell lung cancer patients Feasibility and outcome of reproducible clinical interpretation of high-dimensional molecular data: a comparison of two molecular tumor boards EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy Comprehensive genomic and epigenomic analysis in cancer of unknown primary guides molecularly-informed therapies despite heterogeneity Erratum zu: Gene und Pathways: FGFR2-Translokationen und Fusionsanalytik Gene und Pathways: FGFR2‑Translokationen und Fusionsanalytik Major clinical benefit from adjuvant chemotherapy for stage II–III non-small cell lung cancer patients aged 75 years or older: a propensity score-matched analysis Pan-cancer analysis of genomic scar patterns caused by homologous repair deficiency (HRD) Struktur und Inhalt der EU-IVDR : Bestandsaufnahme und Implikationen für die Pathologie Correction to: Deconvolution of sarcoma methylomes reveals varying degrees of immune cell infiltrates with association to genomic aberrations Case Report: Abdominal Lymph Node Metastases of Parathyroid Carcinoma: Diagnostic Workup, Molecular Diagnosis, and Clinical Management EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy Molecular matched targeted therapies for primary brain tumors - a single center retrospective analysis Molecular Subtyping of Invasive Breast Cancer Using a PAM50-Based Multigene Expression Test-Comparison with Molecular-Like Subtyping by Tumor Grade/Immunohistochemistry and Influence on Oncologist’s Decision on Systemic Therapy in a Real-World Setting GOPC:ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma types Brigatinib versus other second-generation ALK inhibitors as initial treatment of anaplastic lymphoma kinase positive non-small cell lung cancer with deep phenotyping: study protocol of the ABP trial Deciphering the immunosuppressive tumor microenvironment in ALK- and EGFR-positive lung adenocarcinoma SWI/SNF-deficient undifferentiated/rhabdoid carcinoma of the gallbladder carrying a POLE mutation in a 30-year-old woman: a case report Deconvolution of sarcoma methylomes reveals varying degrees of immune cell infiltrates with association to genomic aberrations Role of Synaptophysin, Chromogranin and CD56 in adenocarcinoma and squamous cell carcinoma of the lung lacking morphological features of neuroendocrine differentiation: a retrospective large-scale study on 1170 tissue samples Corrigendum to "Biomarker testing in non-small cell lung cancer in routine care: Analysis of the first 3,717 patients in the German prospective, observational, nation-wide CRISP registry (AIO-TRK-0315)" [Lung Cancer 152 (2021) 174–184] Deciphering the immunosuppressive tumor microenvironment in ALK- and EGFR-positive lung adenocarcinoma Diagnostik und Therapie von Tumoren mit NTRK-Genfusionen = Diagnosis and therapy of tumors with NTRK gene fusion Early identification of disease progression in ALK-rearranged lung cancer using circulating tumor DNA analysis Hidden treasures: macrophage long non-coding RNAs in lung cancer progression Hidden Variables in Deep Learning Digital Pathology and Their Potential to Cause Batch Effects: Prediction Model Study Targeting DNA damage repair mechanisms in pancreas cancer Novel GATA6-FOXO1 fusions in a subset of epithelioid hemangioma Diagnostik und Therapie von Tumoren mit NTRK-Genfusionen Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancer Durvalumab in frail and elderly patients with stage four non-small cell lung cancer: Study protocol of the randomized phase II DURATION trial Comparison of Prostate MRI Lesion Segmentation Agreement Between Multiple Radiologists and a Fully Automatic Deep Learning System Adaptive immunity and pathogenesis of diabetes: insights provided by the α4–integrin deficient NOD mouse Biomarker testing in non-small cell lung cancer in routine care: Analysis of the first 3,717 patients in the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315) Diagnostik und Therapie von Tumoren mit NTRK-Genfusionen Longitudinal therapy monitoring of ALK-positive lung cancer by combined copy number and targeted mutation profiling of cell-free DNA Mass Spectrometry Imaging Differentiates Chromophobe Renal Cell Carcinoma and Renal Oncocytoma with High Accuracy The BRCA2 mutation status shapes the immune phenotype of prostate cancer Morphomolecular analysis of the immune tumor microenvironment in human head and neck cancer Von der Paneldiagnostik zu umfassenden genomischen Analysen : Informationsüberfluss oder Zugewinn? Defective homologous recombination DNA repair as therapeutic target in advanced chordoma Combined Immunohistochemistry after Mass Spectrometry Imaging for Superior Spatial Information

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Albrecht Stenzinger

Molecular diagnostics of hepatobiliary and pancreatic neoplasias

Stratifying esophago-gastric cancer treatment using a patient-derived organoid-based threshold

AWMF statement on medical services in laboratory diagnostics and pathology with regard to the IVDR

Benchmarking whole exome sequencing in the German network for personalized medicine

First-line immunotherapy for lung cancer with MET exon 14 skipping and the relevance of TP53 mutations

First-line immunotherapy for lung cancer with MET exon 14 skipping and the relevance of TP53 mutations

Der Biomarker POLE in der Tumorpathologie

Acute expression of human APOBEC3B in mice results in RNA editing and lethality

Addressing image misalignments in multi-parametric prostate MRI for enhanced computer-aided diagnosis of prostate cancer

NCT/DKFZ MASTER handbook of interpreting whole-genome, transcriptome, and methylome data for precision oncology

Nivolumab and ipilimumab in recurrent or refractory cancer of unknown primary: a phase II trial

Multicentric pilot study to standardize clinical whole exome sequencing (WES) for cancer patients

Current challenges and practical aspects of molecular pathology for non-small cell lung cancers

High EVI1 and PARP1 expression as favourable prognostic markers in high-grade serous ovarian carcinoma

Erratum: Molekulare Tumordiagnostik als Triebfeder der Präzisionsonkologie

An uncommon cause of recurrent presyncope, dizziness, and tachycardia: a case report of diffuse, adult-onset nesidioblastosis/non-insulinoma pancreatogenous hypoglycemia syndrome (NIPHS)

Diffuse, adult-onset nesidioblastosis/non-insulinoma pancreatogenous hypoglycemia syndrome (NIPHS): review of the literature of a rare cause of hyperinsulinemic hypoglycemia

Multicentric pilot study to standardize clinical whole exome sequencing (WES) for cancer patients

Longitudinal monitoring of cell-free DNA methylation in ALK-positive non-small cell lung cancer patients

Feasibility and outcome of reproducible clinical interpretation of high-dimensional molecular data: a comparison of two molecular tumor boards

EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy

Comprehensive genomic and epigenomic analysis in cancer of unknown primary guides molecularly-informed therapies despite heterogeneity

Erratum zu: Gene und Pathways: FGFR2-Translokationen und Fusionsanalytik

Gene und Pathways: FGFR2‑Translokationen und Fusionsanalytik

Major clinical benefit from adjuvant chemotherapy for stage II–III non-small cell lung cancer patients aged 75 years or older: a propensity score-matched analysis

Pan-cancer analysis of genomic scar patterns caused by homologous repair deficiency (HRD)

Struktur und Inhalt der EU-IVDR : Bestandsaufnahme und Implikationen für die Pathologie

Correction to: Deconvolution of sarcoma methylomes reveals varying degrees of immune cell infiltrates with association to genomic aberrations

Case Report: Abdominal Lymph Node Metastases of Parathyroid Carcinoma: Diagnostic Workup, Molecular Diagnosis, and Clinical Management

EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy

Molecular matched targeted therapies for primary brain tumors - a single center retrospective analysis

Molecular Subtyping of Invasive Breast Cancer Using a PAM50-Based Multigene Expression Test-Comparison with Molecular-Like Subtyping by Tumor Grade/Immunohistochemistry and Influence on Oncologist’s Decision on Systemic Therapy in a Real-World Setting

GOPC:ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma types

Brigatinib versus other second-generation ALK inhibitors as initial treatment of anaplastic lymphoma kinase positive non-small cell lung cancer with deep phenotyping: study protocol of the ABP trial

Deciphering the immunosuppressive tumor microenvironment in ALK- and EGFR-positive lung adenocarcinoma

SWI/SNF-deficient undifferentiated/rhabdoid carcinoma of the gallbladder carrying a POLE mutation in a 30-year-old woman: a case report

Deconvolution of sarcoma methylomes reveals varying degrees of immune cell infiltrates with association to genomic aberrations

Role of Synaptophysin, Chromogranin and CD56 in adenocarcinoma and squamous cell carcinoma of the lung lacking morphological features of neuroendocrine differentiation: a retrospective large-scale study on 1170 tissue samples

Corrigendum to "Biomarker testing in non-small cell lung cancer in routine care: Analysis of the first 3,717 patients in the German prospective, observational, nation-wide CRISP registry (AIO-TRK-0315)" [Lung Cancer 152 (2021) 174–184]

Deciphering the immunosuppressive tumor microenvironment in ALK- and EGFR-positive lung adenocarcinoma

Diagnostik und Therapie von Tumoren mit NTRK-Genfusionen = Diagnosis and therapy of tumors with NTRK gene fusion

Early identification of disease progression in ALK-rearranged lung cancer using circulating tumor DNA analysis

Hidden treasures: macrophage long non-coding RNAs in lung cancer progression

Hidden Variables in Deep Learning Digital Pathology and Their Potential to Cause Batch Effects: Prediction Model Study

Targeting DNA damage repair mechanisms in pancreas cancer

Novel GATA6-FOXO1 fusions in a subset of epithelioid hemangioma

Diagnostik und Therapie von Tumoren mit NTRK-Genfusionen

Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancer

Durvalumab in frail and elderly patients with stage four non-small cell lung cancer: Study protocol of the randomized phase II DURATION trial

Comparison of Prostate MRI Lesion Segmentation Agreement Between Multiple Radiologists and a Fully Automatic Deep Learning System

Adaptive immunity and pathogenesis of diabetes: insights provided by the α4–integrin deficient NOD mouse

Biomarker testing in non-small cell lung cancer in routine care: Analysis of the first 3,717 patients in the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315)

Diagnostik und Therapie von Tumoren mit NTRK-Genfusionen

Longitudinal therapy monitoring of ALK-positive lung cancer by combined copy number and targeted mutation profiling of cell-free DNA

Mass Spectrometry Imaging Differentiates Chromophobe Renal Cell Carcinoma and Renal Oncocytoma with High Accuracy

The BRCA2 mutation status shapes the immune phenotype of prostate cancer

Morphomolecular analysis of the immune tumor microenvironment in human head and neck cancer

Von der Paneldiagnostik zu umfassenden genomischen Analysen : Informationsüberfluss oder Zugewinn?

Defective homologous recombination DNA repair as therapeutic target in advanced chordoma

Combined Immunohistochemistry after Mass Spectrometry Imaging for Superior Spatial Information